(Q44906393)

7 December 2017

title

Current concepts of pharmacotherapy in hypertension: thiazide-type diuretics: ongoing considerations on mechanism of action (English)

1 reference

7 December 2017

0 references

Domenic A Sica

1

1 reference

7 December 2017

publication date

1 November 2004

1 reference

Journal of Clinical Hypertension

7 December 2017

published in

1 reference

7 December 2017

volume

6

1 reference

7 December 2017

issue

11

1 reference

7 December 2017

page(s)

661-664

1 reference

Mechanism of antihypertensive effect of thiazide diuretics

7 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.03902.X

Antihypertensive Comparison of Furosemide With Hydrochlorothiazide for Black Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.03902.X

Furosemide compared with hydrochlorothiazide. Long-term treatment of hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.03902.X

A double-blind randomized crossover trial of two loop diuretics in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.03902.X

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.03902.X

Hydrochlorothiazide versus chlorthalidone: evidence supporting their interchangeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.03902.X

Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.03902.X

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.03902.X

Rationale for fixed-dose combinations in the treatment of hypertension: the cycle repeats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.03902.X

Hydrochlorothiazide is not additive to verapamil in treating essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.03902.X

The relationship of sodium balance and concomitant diuretic therapy to blood pressure response with calcium channel entry blockers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.03902.X

10.1111/J.1524-6175.2004.03902.X

21 January 2018

Identifiers

DOI

1 reference

7 December 2017

1 reference